Oprichting Intravacc B.V.

This motion concerns the establishment of Intravacc B.V., a company focused on vaccine development and production. It aims to strengthen the public health infrastructure by ensuring more domestic control over vaccine manufacturing and supply chains. This procedure primarily affects the pharmaceutical sector and public health administration in the Netherlands, potentially impacting how vaccines are developed and distributed to the public.